Tag: B7-H1 Antigen

Frontline ipilimumab/nivolumab improves OS in advanced NCLSC

Presented By
Prof. Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Trial
Phase 3, CheckMate-227
Conference
ESMO 2019
Type
Peer-reviewed article

26 November 2019 22:05

In hepatocellular carcinoma, CheckMate 459 misses OS endpoint, but some interesting trends emerge

Presented By
Dr Thomas Yau, University of Hong Kong, China
Trial
Phase 3, CheckMate 459
Conference
ESMO 2019
Type
Peer-reviewed article

26 November 2019 20:21
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com